Authorizations for provider-administered medications
At Moda Health, we’re committed to supporting your practice and the care you provide your patients. Follow this guidance for submitting prior authorizations, which includes additional details about medical pharmacy programs.
Multiple paths to approvals
The medication and/or the member’s group will determine whether the request is reviewed through Moda Health directly, or through our trusted partner, Prime Therapeutics. Some medications must be reviewed under the member’s pharmacy benefit (see Pharmacy benefit optimization program below). To help determine which path to follow, review the infused/injectable medication list. If you have questions about the specific group coverage, reach out to our Customer Service team at 888-217-2363. We’re here to help.
How to submit your request
Prime Therapeutics
Online through the self-service Prime Therapeutics Portal
Via phone at 800-424-8114
Moda Health
Online through Benefit Tracker
Via fax Rx Preauthorization to 503-243-5105
Claim check program
Moda Health utilizes a claim check program, which monitors and promotes appropriate use, safety and cost effectiveness of medications prescribed to our members. We do this by reviewing claims post-service, but pre-payment for appropriate frequency, correct units, and eligible diagnosis codes. This program is limited to claims reviewed and to medications infused and/or injected in a professional office, home or outpatient setting.
Prior authorization criteria do not apply for these medications; however, there are covered diagnosis codes and dosing limits for each medication. If the services billed do not meet the criteria, the claims will be subject to review and potentially disallowed.
Claim check medications and requirements:
- Azedra® (iobenguane I-131)
- Bortezomib
- Cinvanti® (aprepitant)
- Fosaprepitant: Emend®; Fosaprepitant Ψ; Focinvez Ψ
- Fulvestrant: Faslodex®; Fulvestrant
- Gemcitabine: Gemzar®; Gemcitabine
- Hicon® (Sodium Iodide I - 131)
- Leuprolide Suspension: Camcevi®, Camcevi ETM®, Eligard®, Fensolvi®, Leuprolide Acetate Depot, Lupron Depot®, Lupron Depot-Ped®, Lutrate Depot®, Vabrinty™
- Lutathera® (lutetium Lu 177 dotatate)
- Metastron™ (Strontium-89 Chloride)
- Pluvicto® (lutetium Lu 177 vipivotide tetraxetan)
- Quadramet® (Samarium Sm 153 Lexidronam)
- Scenesse® (afamelanotide)
- Trelstar® (triptorelin)
- Xofigo® (radium Ra 223 dichloride)
- Zevalin® (ibritumomab tiuxetan)
- Zoladex® (goserelin acetate)
Injectable Medication Criteria
Moda Health Plan Delegates administrative functions to Prime Therapeutics Management.
Some injectable medications are reviewed by Moda Health. Please see the bottom of the Injectable Medication Prior Authorization List to find out which medications should be submitted to Moda Health.
- Abecma® (idecabtagene vicleucel)
- Adcetris® (brentuximab vedotin)
- Adakveo® (crizanlizumab-tmca)
- Adstiladrin® (nadofaragene firadenovec-vncg)
- Adzynma® (ADAMTS13, recombinant-krhn)
- Aflibercept: Ahzantive™; Enzeevu™; Eydenzelt®; Eylea®; Eylea® HD; Opuviz™; Pavblu™; Yesafili™
- Akynzeo® (fosnetupitant/palonosetron)
- Aldurazyme® (laronidase)
- Alhemo® (concinzumab)
- Aloxi® (palonosetron)
- Alpha-1-Proteinase Inhibitors: Aralast NP®; Glassia®; Prolastin®-C; Zemaira®
- Amondys 45 (casimersen)
- Amtagvi® (lifileucel)
- Amvuttra (vutrisiran)
- Anktiva® (nogapendekin alfa inbakicept-pmln)
- Anti-amyloid-β monoclonal antibodies: donanemab-azbt (Kisunla)
- Aphexda™ (motixafortide)
- Aranesp® (darbepoetin alfa)
- Asparlas® (calaspargase pegol-mknl)
- Aucatzyl® (Obecabtagene Autoleucel - Obe-cel)
- Arzerra® (ofatumumab)
- Avlayah™ (tividenofusp alfa-eknm)
- Bavencio® (avelumab)
- Beleodaq® (belinostat)
- Bendamustine: Treanda®; Bendeka®; Belrapzo®; Vivimusta™; Bendamustine Ψ
- Benlysta® (belimumab)
- Beovu® (brolucizumab-dbll)
- Berinert® (C1 Esterase Inhibitor, Human)
- Besponsa® (inotuzumab ozogamicin)
- Beqvez™ (fidanacogene elaparvovec-dzkt)
- Bevacizumab: Alymsys®; Avastin®; Avzivi®; Jobevne™; Mvasi®; Vegzelma®; Zirabev®
- Bizengri® (zenocutuzumab-zbco)
- Blenrep® (belantamab mafodotin-blmf)
- Blincyto® (blinatumomab)
- Bortezomib Velcade®; Boruzu®; Bortezomib§
- Botox® (onabotulinumtoxinA)
- Breyanzi® (lisocabtagene maraleucel)
- Brineura® (cerliponase alfa)
- Briumvi™ (ublituximab-xiiy)
- Bypassing Agents: FEIBA and NovoSeven RT
- Cabazitaxel: Jevtana®; Cabazitaxel§
- Carvykti™ (ciltacabtagene autoleucel)
- Casgevy™ (exagamglogene autotemcel)
- Cerezyme® (imiglucerase)
- Cimzia® (certolizumab pegol)
- Cinqair® (reslizumab)
- Cinryze® (C1 Esterase Inhibitor, Human)
- Coagulation Factor X, human (Coagadex®)
- Coagulation Factor XIII A-Subunit, recombinant (Tretten)
- Columvi™ (glofitamab-gxbm)
- Corticotropin-ACTH: Acthar® Gel (repository corticotropin injection) Cortrophin® Gel (repository corticotropin injection)
- Cosela™ (trilaciclib)
- Cosentyx® (secukinumab)
- Crysvita® (burosumab-twza)
- Cyramza® (ramucirumab)
- Danyelza® (naxitamab-gqgk)
- Darzalex® (daratumumab)
- Darzalex Faspro® (daratumumab and hyaluronidase-fihj)
- Datroway® (datopotamab deruxtecan-dlnk)
- Daxxify® (daxibotulinumtoxinA)
- Denosumab: Prolia®; Jubbonti®; Ospomyv™; Stoboclo®; Denosumab-dssb; Conexxence®; Denosumab-bnht; Xgeva®; Wyost®; Xbryk™; Osenvelt®; Bomyntra®
- Dysport® (abobotulinumtoxinA)
- Eculicumab: Soliris®; Bkemv™; Epysqli®
- Elahere™ (mirvetuximab soravtansine-gynx)
- Elaprase® (idursulfase)
- Elelyso® (taliglucerase alfa)
- Elevidys® (delandistrogene moxeparvovec-rokl)
- Elfabrio® (pegunigalsidase alfa-iwxj)
- Elrexfio™ (elranatamab-bcmm)
- Elzonris™ (tagraxofusp-erzs)
- Empliciti® (elotuzumab)
- Emrelis™ (telisotuzumab vedotin-tllv)
- Encelto™ (revakinagene taroretcel-lwey)
- Enhertu® (fam-trastuzumab deruxtecan-nxki)
- Enjaymo™ (sutimlimab-jome)
- Entyvio® (vedolizumab)
- Epkinly™ (epcoritamab-bysp)
- Epoetin alfa: Epogen®; Procrit®; Retacrit®
- Erbitux® (cetuximab)
- Evenity® (romosozumab-aqqg)
- Evkeeza™ (evinacumab-dgnb)
- Exdensur® (depemokimab-ulaa)
- Exondys 51 (eteplirsen injection)
- Extended Half-life Factor IX Products: Alprolix, Idelvion, and Rebinyn
- Extended Half-life Factor VIII Products: Altuviiio, Adynovate, Eloctate, Esperoct and Jivi
- Fabrazyme® (agalsidase beta)
- Factor V Leiden Thrombophilia
- Factor VIII/VWF Complex: Alphanate®, Humate-P®, and Wilate®
- Factor XIII Concentrate, human (Corifact)
- Fasenra® (benralizumab)
- Feraheme® (ferumoxytol)
- Gamifant® (emapalumab-lzsg)
- Gazyva® (obinutuzumab)
- Givlaari® (givosiran)
- Golimumab: Immgolis INTRI®; Simponi ARIA®
- Halaven® (eribulin)
- Hemgenix® (etranacogene dezaparvovec-drlb)
- Hemlibra® (emicizumab-kxwh)
- Herceptin Hylecta™ (trastuzumab and hyaluronidase-oysk)
- Hyaluronic Acid Derivatives: Durolane®, Euflexxa™, Gel-One®, GelSyn-3™, GenVisc 850®, Hyalgan™, Hymovis®, Monovisc®, Orthovisc™, Supartz/Supartz FX™, Synojoynt, Synvisc™, Synvisc-One™, Triluron™, TriVisc™, VISCO-3™, & sodium hyaluronate 1%
- Hympavzi® (marstacimab-hncq)
- Ilaris® (canakinumab)
- Ilumya® (tildrakizumab-asmn)
- Imaavy™ (nipocalimab-aahu)
- Imdelltra™ (tarlatamab-dlle)
- Imfinzi® (durvalumab)
- Imjudo® (tremelimumab-actl)
- Imlygic™ (talimogene laherparepvec)
- IVIG (immune globulin IV): Asceniv™; Alyglo™; Bivigam®; Flebogamma®; Gamunex-C®; Gammagard® Liquid; Gammagard® S/D; Gammagard Liquid ERC®; Gammaked™; Gammaplex®; Octagam®; Privigen®; Panzyga®; Yimmugo®
- Implantable Shock Absorber for Knee OA Treatment
- Infliximab: Remicade®; Inflectra®; Renflexis™; Avsola®; Infliximab*
- Injectafer® (ferric carboxymaltose injection)
- Inlexzo™ (gemcitabine)
- Itvisma® (onasemnogene abeparvovec-brve)
- Ixempra® (ixabepilone)
- Izervay™ (avacincaptad pegol)
- Jelmyto™ (mitomycin)
- Jemperli® (dostarlimab-gxly)
- Kadcyla® (ado-trastuzumab emtansine)
- Kalbitor® (ecallantide)
- Kanuma® (sebelipase alfa)
- Keytruda® (pembrolizumab)
- Keytruda Qlex™ (pembrolizumab and berahyaluronidase alfa-pmph)
- Kresladi™ (marnetegragene autotemcel)
- Krystexxa® (pegloticase)
- Kymriah® (tisagenlecleucel)
- Kyprolis® (carfilzomib)
- Kyxata™ (carboplatin)
- Lamzede® (velmanase alfa-tycv)
- Lanreotide: Somatuline® Depot; Lanreotide
- Lemtrada® (alemtuzumab)
- Lenmeldy™ (atidarsagene autotemcel)
- Leqembi® (lecanemab-irmb)
- Leqvio® (inclisiran)
- Leukine® (sargramostim)
- Levoleucovorin: Fusilev®; Khapzory™
- Libtayo® (cemiplimab-rwlc)
- Loargys® (pegzilarginase-nbln)
- Long-Acting Granulocyte Colony Stimulating Factors (LA-GCSF): Fulphila®; Fylnetra®; Neulasta®; Nyvepria™; Pegfilgrastimfpgk; Rolvedon®; Ryzneuta®; Stimufend®; Udenyca®; Ziextenzo®
- Loqtorzi™ (toripalimab-tpzi)
- Lumizyme® (alglucosidase alfa)
- Lumoxiti™ (moxetumomab pasudotox-tdfk)
- Lunsumio™ (mosunetuzumab-axgb)
- Lunsumio Velo™ (mosunetuzumab-axgb)
- Luxturna (voretigene neparvovec-rzyl)
- Lyfgenia® (lovotibeglogene autotemcel)
- Lymphir™ (denileukin diftitox-cxdl)
- Lynozyfic™ (linvoseltamab-gcpt)
- Margenza™ (margetuximab-cmkb)
- Marqibo® (vincristine sulfate liposomal)
- Mepsevii® (vestronidase alfa-vjbk)
- Monjuvi® (tafasitamab-cxix)
- Monoferric™ (ferric derisomaltose)
- Mylotarg™ (gemtuzumab ozogamicin)
- Myobloc® (rimabotulinumtoxinB)
- Naglazyme® (galsulfase)
- Nexviazyme™ (avalglucosidase alfa-ngpt)
- Niktimvo™ (axatilimab-csfr)
- Nplate® (romiplostim)
- Nucala® (mepolizumab)
- Nulibry™ (fosdenopterin)
- Ocrevus® (ocrelizumab)
- Ocrevus Zunovo™ (ocrelizumab and hyaluronidase-ocsq)
- Omisirge® (omidubicel-onlv)
- Omvoh™ (mirikizumab-mrkz)
- Onivyde® (irinotecan liposome injection)
- Onpattro (patisiran lipid complex)
- Opdivo® (nivolumab)
- Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy)
- Opdualag™ (nivolumab/relatlimab-rmbw)
- Orencia® (abatacept)
- Oxlumo® (lumasiran)
- Paclitaxel Albumin-Bound: Abraxane®; Paclitaxel Albumin-Bound
- Padcev® (enfortumab vedotin-ejfv)
- Palivizumab (Synagis)
- Papzimeos™ (zopapogene imadenovec-drba)
- Pedmark® (sodium thiosulfate)
- Pemetrexed: Alimta®; Pemfexy™; Pemrydi RTU™; Axtle™; Pemetrexed Ψ
- Penpulimab-KCQX (penpulimab-kcqx)
- Perjeta® (pertuzumab)
- Phesgo™ (pertuzumab, trastuzumab and hyaluronidase-zzxf)
- Piasky™ (crovalimab-akkz)
- Polivy® (polatuzumab vedotin-piiq)
- Pombiliti™ (cipaglucosidase alfa-atga)
- Poteligeo® (mogamulizumab-kpkc)
- Proleukin® (aldesleukin, IL-2)
- Provenge® (sipuleucel-T)
- Qalsody™ (tofersen)
- Qfitlia™ (fitusiran)
- Radicava® (edaravone)
- Ranibizumab: Byooviz™ Cimerli™ Lucentis® Nufymco®
- Reblozyl® (luspatercept-aamt)
- Recombinant antihemophilic factor (Obizur®)
- Revcovi® (elapegademase-lvlr)
- Rituxan Hycela® (rituximab and hyaluronidase human)
- Rituximab: Rituxan®, Truxima®, Ruxience™, Riabni™
- Rivfloza™ (nedosiran)
- Roctavian® (valoctocogene roxaparvovec-rvox)
- Ruconest® (C1 Esterase Inhibitor [recombinant])
- Rybrevant™ (amivantamab-vmjw)
- Rybrevant Faspro™ (amivantamab and hyaluronidase-lpuj)
- Rylaze® (asparaginase Erwinia chrysanthemi (recombinant)-rywn)
- Ryoncil® (remestemcel-L-rknd)
- Rystiggo® (rozanolixizumab-noli)
- Rytelo® (imetelstat)
- Ryzneuta® (efbemalenograstim alfa-vuxw)
- Sandostatin® LAR (octreotide suspension)
- Saphnelo® (anifrolumab-fnia)
- Sarclisa® (isatuximab-irfc)
- SCIG (immune globulin SQ): Hizentra®, Gammagard Liquid®, Gamunex®-C, Gammaked™, HyQvia®, Cuvitru®, Cutaquig®, Xembify®
- Short-Acting Granulocyte Colony Stimulating Factors (SA-gCSF): Filgrastim (Neupogen®); Filgrastim-aafi (Nivestym™); Filgrastim-sndz (Zarxio®); Filgrastim-ayow (Releuko®); Tbo-Filgrastim (Granix®); Filgrastim-txid (Nypozi™)
- Signifor® LAR (pasireotide)
- Skyrizi® (risankizumab-rzaa)
- Skysona® (elivaldogene autotemcel)
- Spevigo® (spesolimab)
- Spevigo® (spesolimab) SQ
- Spinal Cord Stimulators
- Spinraza® (nusinersen)
- (Spravato™) esketamine
- Standard Half-life Factor VIII Products: Advate, Afstyla, Hemofil M, Koate DVI, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, and Xyntha
- Standard Half-life Factor IX Products: AlphaNine SD, BeneFIX, Ixinity, MonoNine, Profilnine SD, and Rixubis
- Sustol® (granisetron extended-release) (Subcutaneous) Document
- Susvimo™ (ranibizumab)
- Syfovre™ (pegcetacoplan)
- Sylvant® (siltuximab)
- Talvey™ (talquetamab-tgvs)
- Tecartus® (brexucabtagene autoleucel)
- Tecentriq® (atezolizumab)
- Tecelra® (afamitresgene autoleucel)
- Tecentriq Hybreza™ (atezolizumab and hyaluronidase-tqjs)
- Tecvayli™ (teclistamab-cqyv)
- Tepezza® (teprotumumab-trbw)
- Tevimbra™ (tislelizumab-jsgr)
- Tezspire® (tezepelumab-ekko)
- Trabectedin Evdi; Yondelis®
- Tivdak® (tisotumab vedotin-tftv)
- Tocilizumab: Actemra®; Tofidence™; Tyenne®; Avtozma®; Tocilizumab-anoh§; Tocilizumab-aazg§
- Trastuzumab: Herceptin®; Hercessi™; Herzuma®; Kanjinti®; Ogivri®; Ontruzant®; Trastuzumab-pkrb§; Trazimera®
- Tremfya® (guselkumab)
- Trogarzo™ (ibalizumab-uiyk)
- Trodelvy® (sacituzumab govitecan-hziy)
- Natalizumab: (Tysabri®; Tyruko®)
- Tzield™ (teplizumab-mzwv)
- Ultomiris® (ravulizumab-cwvz)
- Unloxcyt® (cosibelimab-ipdl)
- Uplizna® (inebilizumab-cdon)
- Ustekinumab: Stelara®; Wezlana™; Selarsdi™; Pyzchiva®; Otulfi™; Imuldosa®; Yesintek™; Steqeyma®; Starjemza™; Ustekinumab-aekn§; Ustekinumab-ttwe§; Ustekinumab-aauz§; Ustekinumab-stba§; Ustekinumab§
- Vabysmo™ (faricimab-svoa)
- Vectibix® (panitumumab)
- Veopoz® (pozelimab-bbfg)
- Viltepso (viltolarsen)
- Vyepti® (eptinezumab-jjmr)
- Vimizim (elosulfase alfa)
- Von Willebrand factor (Vonvendi®)
- VPRIV® (velaglucerase alfa)
- Vyjuvek™ (beremagene geperpavec-svdt)
- Vyloy® (zolbetuximab-clzb)
- Vyondys 53 (golodirsen)
- Vyvgart® (efgartigimod alfa-fcab)
- Vyvgart® Hytrulo (efgartigimod alfa-fcab and hyaluronidase-qvfc)
- Vyxeos® (daunorubicin and cytarabine) liposome
- Winrevair™ (sotatercept-csrk)
- Xenpozyme™ (olipudase alfa)
- Xeomin® (incobotulinumtoxinA)
- Xiaflex (collagenase)
- Xolair® (omalizumab)
- Yartemlea® (narsoplimab-wuug)
- Yervoy® (ipilimumab)
- Yescarta® (axicabtagene ciloleucel)
- Ziihera® (zanidatamab-hrii)
- Zilretta® (triamcinolone acetonide ER)
- Zaltrap® (ziv-aflibercept)
- Zolgensma® (onasemnogene abeparvovec-xioi)
- Zepzelca® (lurbinectedin)
- Zevaskyn™ (prademagene zamikeracel)
- Zulresso (brexanalone)
- Zusduri™ (mitomycin)
- Zynlonta® (loncastuximab tesirine-lpyl)
- Zynteglo® (betibeglogene autotemcel)
- Zynyz™ (retifanlimab-dlwr)
Questions?
We're here to help. Call us toll-free at 888-217-2363 or email medical@modahealth.com.